目的：评价各类降脂药物在冠心病治疗中的研究进展及临床应用情况。
OBJECTIVE: To evaluate the aspect of clinical usage and progress on different lipid-lowering drugs in therapy of coronary heart disease (CHD).
因此，继续研究高疗效、低副作用和价格低廉的降脂药物具有重要的临床实用价值。
Therefore, it has important clinical and practical worth to continue to study lipid-lowing drugs with high curative effect, low side effect and price.
姜黄素是一种药理作用广泛的抗癌及降脂药物，但其抗动脉粥样硬化方面的作用还报道不多。
Curcumine was drug with anticancer, lipid-lowing and other extensive action, but its anti-AS effect was reported seldomly.
本病的治疗以激素及免疫抑制剂为主，辅以抗氧化剂、降脂药物、ACEI类药物及中药等。
The main drug was glucocorticoid and immunity inhibitor, besides antioxidant, ACEI and some Chinese traditional medicine.
降脂治疗在冠心病的治疗中占有重要地位，及早合理地应用降脂药物，可以使冠心病患者获得长期的受益。
Lipid-lowering plays an important role in therapy of CHD. Early and rational use lipid-lowering drugs would be beneficial for patients with CHD in a long term.
虽然如此，对Lipitor和Zocor等含他汀(statins)成分的降脂药物来说，这种多级过程却实施得不错。
Nonetheless, the multistep process has worked well for several cholesterol drugs - including Lipitor and Zocor, which are in a class of drugs known as statins.
降脂药他汀类药物会降低血液胆固醇水平。
Cholesterol-reducing medications. Medications called statins can help lower cholesterol levels.
降脂药他汀类药物会降低血液胆固醇水平。
Cholesterol-reducing medications. Medications called statins can help lower cholesterol levels.
应用推荐